Since there is high adherence to antiplatelets and statins in patients with CHD, which was also observed from our study, more effort on improving medication adherence to β-blockers and ACE inhibitor/ARBs should be strengthened in future studies. This evidence concerns the gene ACE and coronary artery disorder.